David Morgan, PhD
Dave Morgan is Chief Executive Officer/Director of the USF Health Byrd Alzheimer Institute, Distinguished Professor of Molecular Pharmacology and Physiology, and Director of Neuroscience Research for the College of Medicine and at the University of South Florida. Dr. Morgan’s research interests are aging and brain function, focusing on drugs to treat Alzheimer’s dementia. Morgan participated in the development of a transgenic mouse model of Alzheimer’s disease (APP+PS1). His work focuses largely on the neuro-immune interactions associated with the Alzheimer phenotype, and the role of astrocytes and microglia in the disease process. He is presently testing anti-amyloid immunotherapy and gene therapy to treat the Alzheimer-like changes in transgenic mouse models of the disease. This work is supported by multiple grants from the NIH, private foundations and contracts from industrial partners. Morgan regularly sits on review panels for NIH and other agencies evaluating grants to develop new drugs to treat Alzheimer’s and other neurodegenerative disorders.
Please click here to view Dr. Morgan’s CV.
Burt Anderson, PhD
Burt Anderson is a professor in the Department of Molecular Medicine, College of Medicine at the University of South Florida. Dr. Anderson’s primary focus is how facultative intracellular bacteria control expression of genes required for virulence. Currently he is also an infectious disease researcher at VA (Veteran’s Affairs) Medical Center, Bay Pines, FL and graduate coordinator for the Signature Program in Allergy, Immunology, and Infectious Diseases Doctoral Program, as well as, course director and developer of Foundations in Medical Microbiology and Immunology.
Please click here to view Dr. Anderson’s CV.
Dominic D’Agostino, PhD
Dr. D’Agostino conducts research on the Deanna Protocol® in his laboratory at the University of South Florida (USF). He is an Assistant Professor at the USF’s Department of Molecular Pharmacology and Physiology in Tampa, FL. Dr. D’Agostino is currently developing and testing metabolic strategies to treat ALS and other neurodegenerative diseases. He is also testing the efficacy of hyperbaric oxygen therapy for neurological diseases, wound healing, and cancer. In addition, Dr. D’Agostino is studying the neuroprotective mechanism of the ketogenic diet and “therapeutic Ketosis”. He received a Ph.D. in physiology and neuroscience from the University Of Medicine and Dentistry Of New Jersey.
Please click here to view Dr. D’Agostino’s CV.
Csilla Ari, PhD
Dr. Csilla Ari conducts research on the Deanna Protocol® in her laboratory at the University of South Florida. Dr. Ari is currently a postdoctoral scholar at the Byrd Alzheimer’s Center and Research Institute of University of South Florida’s Department of Molecular Medicine in Tampa, FL. In addition to her research for Winning the Fight, Dr. Ari is currently researching impairments connected to defective microtubule motor protein in Alzheimer`s disease and other neurodegenerative diseases. Dr. Ari earned a Ph.D. in neuroscience from Semmelweis Medical University in Budapest, Hungary, and a MS in zoology from Szent István Univeristy, also in Budapest.
Please click here to view Dr. Ari’s CV.
Christopher Q. Rogers, PhD
Dr. Christopher Rogers conduct research on the Deanna Protocol® in his laboratory at the University of South Florida. Dr. Rogers is currently a research scientist responsible for organizing projects in basic and clinical medicine, mentoring graduate students, and teaching graduate level classes in pharmacology and physiology. He also instructs graduate level classes in pharmacology and physiology, writes and reviews grants and peer-reviewed scientific articles, and oversees various organizational and operational issues related to efficient laboratory function. He has experience at Moffitt Cancer and Research Institute, Biotronic, and The RAN Institute.
Vincent M. Tedone M.D.
Dr. Vincent Tedone discovered the Deanna Protocol® Metabolic Plan (DP™ plan) and currently establishes the focus and goals for all research on the DP™ plan. Dr. Tedone also is Chief Medical Liaison to the medical and science communities on behalf of Winning the Fight, Inc., the non-profit organization responsible for funding the DP™ plan research. He also serves as medical consultant and liaison to individuals who are on the DP™ plan. Dr. Tedone discovered the DP™ plan through years of research on cell metabolism and its impact on nerve cells. He used his in-depth knowledge of Biochemistry to find possible ways to stop the death of nerve cells in individuals with ALS and other nerve diseases. Dr. Tedone developed the present day Deanna Protocol® using knowledge gathered from his research, anecdotal evidence, and evidence resulting from scientific studies. Prior to Dr. Tedone’s daughter Deanna’s diagnosis with ALS, Dr. Tedone was an orthopedic surgeon. He operated on professional and college athletes and introduced several new surgical techniques, which are now popular, into the field of orthopedics. He retired from a 34 year career in medicine in 1997.